Literature DB >> 29308278

ABO blood groups and rheumatic diseases.

Songül Çildağ1, Yasemin Kara1, Taşkın Şentürk1.   

Abstract

OBJECTIVE: Various genetic and environmental risk factors have been shown to be associated with the incidence of rheumatic diseases. However, the pathogenesis of rheumatic diseases poorly understood. Several studies have shown associations of ABO blood groups with various diseases. Our study aimed to determine whether there is an association between the types of rheumatic diseases and ABO and Rh blood groups.
MATERIAL AND METHODS: The study included the patients, followed up at the Immunology-Rheumatology clinic between January 2016 and December 2016 for diagnosis of rheumatic disease, who had an ABO Rh blood data. Age, gender, type of rheumatic disease, ABO Rh blood groups were recorded.
RESULTS: When 823 patients were assessed for blood types, 42.5% patients had A type, 33.2% had O type, 15.4% had B type, and 8.9% had AB type. There was significant difference in the distribution of blood types in rheumatic diseases. While SpA, vasculitis, UCTD, Behçet's and RA were more common in the patients with A blood type; FMF, SLE, SSc and SjS were more common in the patients with O blood type. In addition, the blood type where all the diseases are observed the least commonly was AB. There was significant difference in the distribution of Rh factor in rheumatic diseases. 92.2% patients were Rh positive and 7.8% patients were Rh negative.
CONCLUSION: In our study, we thought that the higher incidence of different rheumatic diseases in different blood types was associated with different genetic predisposition.

Entities:  

Keywords:  ABO blood group; rh factor; rheumatic diseases

Year:  2017        PMID: 29308278      PMCID: PMC5741336          DOI: 10.5152/eurjrheum.2017.17044

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  24 in total

Review 1.  Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases.

Authors:  Jeffrey A Sparks; Karen H Costenbader
Journal:  Rheum Dis Clin North Am       Date:  2014-09-02       Impact factor: 2.670

2.  The preclinical phase of rheumatoid arthritis: what is acknowledged and what needs to be assessed?

Authors:  H W van Steenbergen; T W J Huizinga; A H M van der Helm-van Mil
Journal:  Arthritis Rheum       Date:  2013-09

3.  Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.

Authors:  Timothy R D J Radstake; Olga Gorlova; Blanca Rueda; Jose-Ezequiel Martin; Behrooz Z Alizadeh; Rogelio Palomino-Morales; Marieke J Coenen; Madelon C Vonk; Alexandre E Voskuyl; Annemie J Schuerwegh; Jasper C Broen; Piet L C M van Riel; Ruben van 't Slot; Annet Italiaander; Roel A Ophoff; Gabriela Riemekasten; Nico Hunzelmann; Carmen P Simeon; Norberto Ortego-Centeno; Miguel A González-Gay; María F González-Escribano; Paolo Airo; Jaap van Laar; Ariane Herrick; Jane Worthington; Roger Hesselstrand; Vanessa Smith; Filip de Keyser; Fredric Houssiau; Meng May Chee; Rajan Madhok; Paul Shiels; Rene Westhovens; Alexander Kreuter; Hans Kiener; Elfride de Baere; Torsten Witte; Leonid Padykov; Lars Klareskog; Lorenzo Beretta; Rafaella Scorza; Benedicte A Lie; Anna-Maria Hoffmann-Vold; Patricia Carreira; John Varga; Monique Hinchcliff; Peter K Gregersen; Annette T Lee; Jun Ying; Younghun Han; Shih-Feng Weng; Christopher I Amos; Fredrick M Wigley; Laura Hummers; J Lee Nelson; Sandeep K Agarwal; Shervin Assassi; Pravitt Gourh; Filemon K Tan; Bobby P C Koeleman; Frank C Arnett; Javier Martin; Maureen D Mayes
Journal:  Nat Genet       Date:  2010-04-11       Impact factor: 38.330

4.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

5.  Blood groups ABO and Rh (D) factor in the rheumatic diseases.

Authors:  I Stoia; R Ramneantu; M Poitas
Journal:  Ann Rheum Dis       Date:  1967-07       Impact factor: 19.103

6.  Association of ABO and Rh blood groups with type 2 diabetes mellitus.

Authors:  S A Meo; F A Rouq; F Suraya; S Z Zaidi
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016       Impact factor: 3.507

Review 7.  Genetics of spondyloarthritis--beyond the MHC.

Authors:  John D Reveille
Journal:  Nat Rev Rheumatol       Date:  2012-04-10       Impact factor: 20.543

Review 8.  The histo-blood group ABO system and tissue transplantation.

Authors:  T Eastlund
Journal:  Transfusion       Date:  1998-10       Impact factor: 3.157

9.  Does immune activation continue during an attack-free period in familial Mediterranean fever?

Authors:  U Musabak; A Sengul; C Oktenli; S Pay; Z Yesilova; L Kenar; S Y Sanisoglu; A Inal; A Tuzun; A Erdil; S Bagci
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

10.  Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis.

Authors:  Soumya Raychaudhuri; Cynthia Sandor; Eli A Stahl; Jan Freudenberg; Hye-Soon Lee; Xiaoming Jia; Lars Alfredsson; Leonid Padyukov; Lars Klareskog; Jane Worthington; Katherine A Siminovitch; Sang-Cheol Bae; Robert M Plenge; Peter K Gregersen; Paul I W de Bakker
Journal:  Nat Genet       Date:  2012-01-29       Impact factor: 38.330

View more
  2 in total

1.  Clinical Impact of the ABO Blood Type in Patients with Rheumatic Diseases: Is there a Link to the ABO and Rhesus?

Authors:  Gehan I Salem; Nada M Gamal; Esraa A Talaat; Dina H El-Hammady; Nevin Hammam; Tamer A Gheita
Journal:  Mediterr J Rheumatol       Date:  2021-09-30

2.  ABO and Rh blood groups in patients with lupus and rheumatoid arthritis.

Authors:  Amir Nik; Zahra Mirfeizi; Zahra Rezaieyazdi; Mandana Khodashahi; Shahin Danevash; Mohammad Sobhan Sheikh Andalibi; Mahnaz Abbasi; Maryam Sahebari
Journal:  Caspian J Intern Med       Date:  2021
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.